Dizziness related disorders are one of the most common forms of disability impacting quality of life today. Prevalent more among adults as they advance in age, dizziness has become one of the most commons type of chronic disabilities, affecting between 9-11% of the population.
Read articlePalo Alto and Boston – March 29, 2022– SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announces today the expansion of its clinical advisory board and the creation of a specific advisory panel of Physical Therapy providers, to assist the company with growing product demand and market opportunities.
Read articleThis month, we’ll be launching the newest integrated Virtual Reality (VR) headset from our partners at Pico Interactive, the Neo 3 Pro Eye.
Read articlePalo Alto and Boston–March 9, 2022– SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announces today the expansion of its partnership with Pico Interactive, a global technology company that develops innovative VR and enterprise solutions, and the integration of its platform onto the Pico Neo 3 Pro Eye headset.
Read articleAs technological innovation continues to outpace the evolution of healthcare practices, a fundamental shift is occurring. Patient centered care is no longer, having been replaced by consumer directed care. Consumers have shifted away from reactionary “sick” care options, opting to instead gravitate towards technology to monitor their own health and wellness.
Read articleFor many of us, 2021 can be summed up in just a few words.
Unpredictable. Scary. Chaotic. Promising. Hopeful.
Whatever your preference, it is likely we can agree that these uncertain times has forced all of us to think outside the box, to adapt to changing circumstances, and to learn new things and to do them in unique ways. We at SyncThink…
Read articlePalo Alto and Boston—October 5, 2021— SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announces today the US Food and Drug Administration (FDA) has granted clearance of the EYE-SYNC technology as an Aid to Concussion, or mild Traumatic Brain Injury (mTBI) Diagnosis. EYE-SYNC previously received the prestigious Breakthrough Device Designation from the FDA in 2019, following the initial clearance and commercialization of the technology platform in 2017.
Read articleJune 3, 2021 In cased you missed it, check out our feature on us written by our partners at Tobii: https://blog.tobii.com/seeking-out-the-keys-to-scalability-to-democratize-brain-health-assessment By Maggie Ma For this innovation story, I sat with Scott Anderson, chief clinical officer at SyncThink — an expanding Palo-Alto tech company that has recently launched the third generation of its brain health […]
Read articlePalo Alto and Boston – April 5, 2021– SyncThink, a next gen neurotechnology company and developer of the award-winning EYE-SYNC technology, announces today it has partnered with Tobii, the world leader in eye tracking, and Pico Interactive, a global technology company that develops innovative VR and enterprise solutions. The company will provide EYE-SYNC on the Pico Neo 2 Eye, which was recently named one of TIME’s best inventions of 2020.
Read articlePalo Alto, CA—January 04, 2021— SyncThink, a world leader in neurotechnology with foundational IP in eye-tracking analytics, and creators of the award-winning EYE-SYNC brain health platform, announces today its partnership with Daybrook Strategies of Saint Louis. Daybrook, a joint venture between local providers Advanced Neuro Performance and The Center for Vision and Learning, plan to incorporate the novel eye tracking solution as part of an effort to develop a statewide concussion management program.
Read articleIn 2018, the United States Department of Defense (DoD) embarked on a bold new path designed to re-imagine and modernize the soldier of the future. In a changing world with diplomatic tensions rising and new adversaries emerging, DoD sensed their longstanding military advantage and strategies to prevent conflict were waning. With global society dependent on […]
Read articleAccuracy vs Precision For several EYE-SYNC assessments, including Saccades, VOR, and VORx, eye-target synchronization is measured by reporting on the metrics of precision and accuracy. While these concepts are closely related, there are important distinguishing factors to master for any clinician utilizing these metrics in their workflow. At the highest level, the precision of eye […]
Read article